Biopharma Industry Review: A Year of Challenges and Changes in 2023

by Andrii Buvailo, PhD          Biopharma insight

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   604    Comments 0
Topics: Industry Trends   
Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email

The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number of bankruptcies. According to PitchBook, the industry raised approximately $24 billion in 2023, a stark decline from the higher funding levels of the previous three years, which saw annual figures of $38.1 billion, $53.9 billion, and $36.9 billion, respectively.

Exit activities also slowed down, with only 84 deals totaling $17.9 billion. This decrease was largely attributed to fewer initial public offerings. The sector also witnessed the impact of a biosimilar onslaught and a steep patent cliff, with several drugs losing exclusivity by the year's end.

 

Adapting Strategies Amid Economic Pressure

Faced with this challenging business environment, companies across the biopharma sector have been compelled to rethink their market strategies and cut costs. This has led to reductions in investments in research and development (R&D), streamlining of product pipelines, and widespread layoffs.

Continue reading

This content available exclusively for BPT Mebmers

Topics: Industry Trends   

Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email

Comments:

There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *